CT
RMD icon

Clearstead Trust’s ResMed RMD Stock Holding History

Clearstead Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7K Buy
106
+54
+104% +$11.2K ﹤0.01% 455
2026
Q1 		$11.7K Buy
52
+26
+100% +$6.48K ﹤0.01% 539
2025
Q4 		$6.26K Buy
26
+15
+136% +$3.84K ﹤0.01% 705
2025
Q3 		$3.01K Hold
11
– – ﹤0.01% 884
2025
Q2 		$2.84K Buy
+11
New +$2.62K ﹤0.01% 868

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Clearstead Trust's RMD Position: Q2 2026 in Review

Clearstead Trust increased its ResMed (RMD) stake by 104% in Q2 2026, buying an estimated $11.2K and bringing the position to 106 shares worth $20.7K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

Clearstead Trust first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Clearstead Trust held 106 shares of ResMed worth $20.7K as of Q2 2026.
  • Clearstead Trust bought 54 ResMed shares in Q2 2026, an estimated $11.2K.
  • ResMed made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #455 holding.
  • Clearstead Trust first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.